Quantcast

Latest Savient Pharmaceuticals Inc. Stories

2011-04-21 15:05:00

EAST BRUNSWICK, N.J., April 21, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the company will release financial results for the first quarter 2011 prior to the open of the market on Thursday, May 5, 2011. John H.

2011-03-08 15:10:00

EAST BRUNSWICK, N.J., March 8, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that Paul Hamelin, R.Ph., President of Savient will present at the ROTH 23rd Annual OC Growth Stock Conference on Tuesday, March 15, at 11:00 a.m. Pacific Time.

2011-03-02 15:10:00

EAST BRUNSWICK, N.J., March 2, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that John H. Johnson, Chief Executive Officer of Savient will present at the 31st Annual Cowen & Co. Health Care Conference, on Monday, March 7, 2011, at 1:00 p.m. Eastern Time.

2011-02-25 06:00:00

EAST BRUNSWICK, N.J. Feb. 25, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the official full U.S. commercial launch of KRYSTEXXA(TM) (pegloticase), which has been approved by the U.S.

2011-02-17 15:30:00

EAST BRUNSWICK, N.J., Feb. 17, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that John H. Johnson, Chief Executive Officer of Savient will present at the Citi 2011 Global Healthcare Conference on Tuesday, March 1, 2011, at 4:00 p.m. Eastern Time.

2011-02-17 07:00:00

EAST BRUNSWICK, N.J., Feb. 17, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today that its fourth quarter and year-end 2010 financial results will be released on Friday, February 25, 2011, at 7:00 a.m. Eastern Time. Following the announcement, John H.

2011-02-16 06:00:00

EAST BRUNSWICK, N.J., Feb. 16, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it is strengthening its management team with three new executive appointments as it begins the commercial launch of KRYSTEXXA(TM).

2011-02-04 15:10:00

EAST BRUNSWICK, N.J., Feb. 4, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the closing of its sale of $230 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes").

2011-02-01 06:00:00

EAST BRUNSWICK, N.J., Feb. 1, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc.

2011-01-31 06:15:00

EAST BRUNSWICK, N.J., Jan. 31, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.